Solid Biosciences upgraded by Piper Sandler with a new price target

3/14/24 8:18:19 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Piper Sandler upgraded Solid Biosciences from Neutral to Overweight and set a new price target of $20.00 from $8.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SLDB

Date	Price Target	Rating	Analyst
1/8/2025	$16.00	Buy	Truist
12/13/2024	$16.00	Outperform	Wedbush
12/10/2024	$15.00	Mkt Outperform	JMP Securities
7/15/2024	$10.00 → $15.00	Neutral → Overweight	JP Morgan
6/24/2024	$12.00	Market Perform → Outperform	Leerink Partners
5/31/2024	$20.00	Overweight	Piper Sandler
3/28/2024	$40.00	Outperform	William Blair
3/15/2024	$16.00	Buy	Citigroup